Regeneron Pharmaceuticals on Track for Largest Percent Decrease Since June 2023 — Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $1111.94, down $33.09 or 2.89%

--Would be lowest close since Aug. 7, 2024, when it closed at $1067.80

--On pace for largest percent decrease since June 27, 2023, when it fell 8.71%

--Currently down six of the past seven days

--Currently down two consecutive days; down 3.33% over this period

--Worst two day stretch since the two days ending Sept. 6, 2024, when it fell 4.06%

--Down 6.14% month-to-date; on pace for worst month since April 2024, when it fell 7.46%

--Up 26.6% year-to-date

--Down 7.47% from its all-time closing high of $1201.76 on Aug. 27, 2024

--Up 33.22% from 52 weeks ago (Sept. 25, 2023), when it closed at $834.64

--Down 7.47% from its 52-week closing high of $1201.76 on Aug. 27, 2024

--Up 43.44% from its 52-week closing low of $775.18 on Oct. 27, 2023

--Traded as low as $1097.00; lowest intraday level since Aug. 8, 2024, when it hit $1069.03

--Down 4.19% at today's intraday low; largest intraday percent decrease since June 28, 2023, when it fell as much as 4.37%

--Worst performer in the S&P 500 today

--Second worst performer in the Nasdaq 100 today

All data as of 12:52:18 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 23, 2024 13:09 ET (17:09 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.